# A simple, sensitive and rapid bioanalytical method for quantifying cannabidiol (CBD), 7-OH-CBD and 7-COOH-CBD in human plasma. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/bioanalytical-method-cannabidiol-plasma-quantification/ > **Published:** 2026-03-24T18:08:35-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:40:19-04:00 > **Clinical Summary:** This bioanalytical method cannabidiol plasma quantification offers a simple, sensitive, and rapid approach for measuring CBD and metabolites in human plasma. --- CED Clinical Relevance  #55Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch  |  CED Clinic CbdPharmacokineticsLaboratory MethodsMetabolismResearch Tools Journal Bioanalysis Study Type Clinical Study Population Human participants Why This Matters Accurate measurement of CBD and its metabolites in plasma is fundamental for understanding dosing, therapeutic windows, and individual patient responses. This simplified analytical method could standardize pharmacokinetic research and eventually support therapeutic drug monitoring in clinical practice. Clinical Summary Researchers developed and validated a streamlined bioanalytical method using liquid chromatography-mass spectrometry to simultaneously measure CBD, 7-OH-CBD, and 7-COOH-CBD in human plasma. The method uses simple protein precipitation with acetonitrile rather than complex extraction procedures, achieving complete analyte separation and validation across clinically relevant concentration ranges. This represents a technical advancement in laboratory methodology rather than a clinical trial, with validation parameters including sensitivity, accuracy, precision, and stability testing. Dr. Caplan’s Take “While this is methodological work rather than [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/), reliable plasma measurement tools are the foundation of evidence-based [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). Having simpler, more accessible analytical methods could accelerate the pharmacokinetic studies we desperately need.” Clinical Perspective 🧠 This analytical advancement primarily benefits researchers conducting pharmacokinetic studies of [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/). For clinicians, improved measurement methods may eventually support more precise dosing recommendations and therapeutic monitoring, though such clinical applications remain in development. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20A%20simple%2C%20sensitive%20and%20rapid%20bioanalytical%20method%20for%20quantifying%20cannabidiol%20%28...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41508948/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41508948/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20A%20simple%2C%20sensitive%20and%20rapid%20bioanalytical%20method%20for%20quantifying%20cannabidiol%20%28...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41508948/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41508948/](https://pubmed.ncbi.nlm.nih.gov/41508948/) Table of Contents - [FAQ](#FAQ)[Why is measuring CBD metabolites important for clinical practice?](#Why_is_measuring_CBD_metabolites_important_for_clinical_practice) - [How does this new testing method improve patient care compared to existing methods?](#How_does_this_new_testing_method_improve_patient_care_compared_to_existing_methods) - [What does this mean for patients currently taking CBD medications?](#What_does_this_mean_for_patients_currently_taking_CBD_medications) - [Can this testing method help identify patients who don’t respond well to CBD?](#Can_this_testing_method_help_identify_patients_who_don8217t_respond_well_to_CBD) - [How might this impact CBD drug development and research?](#How_might_this_impact_CBD_drug_development_and_research) - [Related](#Related) ## FAQ #### Why is measuring CBD metabolites important for clinical practice? Measuring CBD metabolites like 7-OH-CBD and 7-COOH-CBD provides crucial information about how patients process CBD, which varies significantly between individuals. This metabolic profiling helps clinicians optimize dosing, predict therapeutic responses, and identify potential drug interactions in CBD therapy. #### How does this new testing method improve patient care compared to existing methods? This simplified bioanalytical method uses basic protein precipitation with acetonitrile, making it faster and more accessible than complex existing procedures. The method’s reliability across clinically relevant plasma concentrations means more healthcare facilities can accurately monitor CBD therapy without specialized equipment. #### What does this mean for patients currently taking CBD medications? Patients may benefit from more precise dosing and better monitoring of their CBD therapy as this accessible testing method becomes available. The ability to measure both parent drug and metabolites allows for personalized treatment adjustments based on individual metabolic patterns. #### Can this testing method help identify patients who don’t respond well to CBD? Yes, by measuring CBD and its active metabolite 7-OH-CBD simultaneously, clinicians can distinguish between poor absorption, rapid metabolism, or inadequate dosing as causes of treatment failure. This information guides whether to adjust doses, change formulations, or consider [alternative treatments](https://cedclinic.com/citral-cannabinoid-receptor-2-activation-pain-relief/). #### How might this impact CBD drug development and research? This robust, simple method enables more comprehensive pharmacokinetic studies across diverse patient populations, potentially accelerating CBD [drug development](https://cedclinic.com/hydrogen-sulfide-releasing-nsaid-derivative/). The standardized approach for measuring CBD metabolism will improve the quality and comparability of clinical trial data. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “A simple, sensitive and rapid bioanalytical method for quantifying cannabidiol (CBD), 7-OH-CBD and 7-COOH-CBD in human plasma.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41508948/”, “about”: “bioanalysis clinical study simple sensitive rapid”, “isPartOf”: “Bioanalysis”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Results of an Exploratory Crossover Pharmacokinetic Study Evaluating a Natural Hemp Extract-Based Cosmetic Product: Comparison of Topical and Oral Routes of Administration.](https://cedclinic.com/topical-hemp-pharmacokinetics-study-systemic-absorption/) Explore pharmacokinetic differences between topical and oral hemp extract applications in this detailed study. [Read More](https://cedclinic.com/topical-hemp-pharmacokinetics-study-systemic-absorption/) [Cannabinoid Effects of Metamizol/Dipyrone: A Possible Second Life in Pediatric Anesthesia for a Vintage Drug.](https://cedclinic.com/metamizol-pediatric-anesthesia-cannabinoid-effects/) Review the potential cannabinoid interactions with metamizol/dipyrone in pediatric anesthesia settings. [Explore Article](https://cedclinic.com/metamizol-pediatric-anesthesia-cannabinoid-effects/) [Lifestyle and Behavioral Enhancements of Sleep: A Review.](https://cedclinic.com/sleep-hygiene-cbt-i-lifestyle-enhancements/) Understand how lifestyle and behavioral changes can improve sleep quality and overall health. [Learn More](https://cedclinic.com/sleep-hygiene-cbt-i-lifestyle-enhancements/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).